Latin America Newborn Screening Market Size & Outlook

The newborn screening market in Latin America is expected to reach a projected revenue of US$ 155.4 million by 2030. A compound annual growth rate of 6.4% is expected of Latin America newborn screening market from 2024 to 2030.

Revenue, 2023 (US$M)
$100.6
Forecast, 2030 (US$M)
$155.4
CAGR, 2024 - 2030
6.4%
Report Coverage
Latin America

Latin America newborn screening market highlights

  • The Latin America newborn screening market generated a revenue of USD 100.6 million in 2023.
  • The market is expected to grow at a CAGR of 6.4% from 2024 to 2030.
  • In terms of segment, tandem mass spectrometry was the largest revenue generating technology in 2023.
  • Electrophoresis is the most lucrative technology segment registering the fastest growth during the forecast period.
  • Country-wise, Argentina is expected to register the highest CAGR from 2024 to 2030.


Latin America data book summary

Market revenue in 2023USD 100.6 million
Market revenue in 2030USD 155.4 million
Growth rate6.4% (CAGR from 2023 to 2030)
Largest segmentTandem mass spectrometry
Fastest growing segmentElectrophoresis
Historical data covered2018 - 2022
Base year for estimation2023
Forecast period covered2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationTandem Mass Spectrometry, Pulse Oximetry, Enzyme-based Assay, DNA Assays, Electrophoresis
Key market players worldwideBio-Rad Laboratories Inc, Agilent Technologies, Agilent Technologies Inc, Covidien, Masimo Corp, Waters Corp, Natus Medical, GE HealthCare Technologies Inc Common Stock, PerkinElmer, Danaher Corp


Other key industry trends

  • In terms of revenue, Latin America region accounted for 12.6% of the global newborn screening market in 2023.
  • Globally, Asia Pacific is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 451.1 million by 2030.

Tandem mass spectrometry was the largest segment with a revenue share of 24.65% in 2023. Horizon Databook has segmented the Latin America newborn screening market based on tandem mass spectrometry, pulse oximetry, enzyme-based assay, dna assays, electrophoresis covering the revenue growth of each sub-segment from 2018 to 2030.


The coverage rate for screening in newborn varies across the 20 countries of Latin America. 100% coverage is observed in Chile, Cuba, and Uruguay, and countries such as El Salvador, Haiti, and Honduras have negligible coverage. Congenital hypothyroidism testing is mandated in ten countries, whereas phenylketonuria testing is compulsory only in Costa Rica, Paraguay, Brazil, Venezuela, Guatemala, and Chile.


However, parents can demand for additional testing depending on the need. Recently, emphasis on cystic fibrosis and hearing screen has gained momentum across the region. In 2012, World Solutions Against Infectious Diseases (WSAID) announced partnership with Save Babies Through Screening Foundation (SBTS) and work for expansion of the screening program with the region.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Newborn Screening Market Companies

Name Profile # Employees HQ Website

Latin America newborn screening market size, by country, 2018-2030 (US$M)

Latin America Newborn Screening Market Outlook Share, 2023 & 2030 (US$M)

Latin America newborn screening market size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more